GFM
TWST icon

GF Fund Management’s Twist Bioscience TWST Stock Holding History

GF Fund Management’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$134K Sell
1,300
-73
-5% -$4.75K ﹤0.01% 305
2026
Q1 		$65.2K Buy
1,373
+172
+14% +$7.71K ﹤0.01% 372
2025
Q4 		$38.1K Sell
1,201
-98
-8% -$3.06K ﹤0.01% 431
2025
Q3 		$36.6K Sell
1,299
-221
-15% -$6.69K ﹤0.01% 426
2025
Q2 		$55.9K Hold
1,520
– – ﹤0.01% 404
2025
Q1 		$59.7K Buy
1,520
+274
+22% +$12.3K ﹤0.01% 403
2024
Q4 		$57.9K Buy
+1,246
New +$56.3K ﹤0.01% 376

Other funds holding TWST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

GF Fund Management's TWST Position: Q2 2026 in Review

GF Fund Management reduced its Twist Bioscience (TWST) stake by 5.3% in Q2 2026, selling an estimated $4.75K and leaving 1,300 shares worth $134K. The position accounts for ﹤0.01% of the portfolio, ranked #305.

GF Fund Management first reported a position in TWST in Q4 2024 and has held it in 7 quarters since. 338 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • GF Fund Management held 1,300 shares of Twist Bioscience worth $134K as of Q2 2026.
  • GF Fund Management sold 73 Twist Bioscience shares in Q2 2026, an estimated $4.75K.
  • Twist Bioscience made up ﹤0.01% of GF Fund Management's portfolio in Q2 2026, its #305 holding.
  • GF Fund Management first reported a position in Twist Bioscience in Q4 2024 and has held it in 7 quarters since.
  • 338 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on GF Fund Management's 13F filing for Q2 2026, filed 7 Aug 2026.